SANUWAVE Health (SNWV) Cash from Financing Activities (2010 - 2026)
SANUWAVE Health's (SNWV) quarterly Cash from Financing Activities came in at -$1.4 million in Q2 2026, down 956.52% year-over-year from $161000.0 in Q2 2025, and up 2.82% quarter-over-quarter from -$1.4 million in Q1 2026.
Analysis
SANUWAVE Health (SNWV) Cash from Financing Activities (2010 - 2026) Analysis & Trends
SANUWAVE Health (SNWV) has reported Cash from Financing Activities for 16 consecutive years, with -$1.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 956.52% year-over-year to -$1.4 million in Q2 2026; TTM through Jun 2026 was -$8.5 million, a 238.21% decrease from a year earlier, with the FY2025 full-year figure at -$5.6 million, down 187.93% from the prior year.
- Cash from Financing Activities was -$1.4 million for Q2 2026 at SANUWAVE Health, up from -$1.4 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $7.6 million in Q3 2022 and troughed at -$4.4 million in Q3 2025.
- A 5-year average of $1.1 million and a median of $217500.0 in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 1943.29% in 2022 and sank 2389.47% in 2026, its largest moves.
- Over 5 years, Cash from Financing Activities stood at $4.7 million in 2022, then plunged by 60.7% to $1.9 million in 2023, then soared by 248.95% to $6.5 million in 2024, then sank by 119.17% to -$1.2 million in 2025, then declined by 11.12% to -$1.4 million in 2026.
- The last three Cash from Financing Activities figures came in at -$1.4 million (Q2 2026), -$1.4 million (Q1 2026), and -$1.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -213.50 Mn |
| 10 | SANUWAVE Health | 34.83 Mn | 25.46 Mn | 7.42 Mn | -1.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.38 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Sep 30, 2025 | -4.45 Mn |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | -57,000.00 |
| Dec 31, 2024 | 6.47 Mn |
| Sep 30, 2024 | -435,000.00 |
| Jun 30, 2024 | 274,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | -654,000.00 |
| Dec 31, 2022 | 4.72 Mn |
| Sep 30, 2022 | 7.56 Mn |
| Jun 30, 2022 | 2.63 Mn |
| Mar 31, 2022 | 2.47 Mn |
| Dec 31, 2021 | 231,000.00 |
| Sep 30, 2021 | 1.53 Mn |